Skip to content

Herbo-metallic Formulation and Ferrous sulphate in Pandu Roga (Iron Deficiency Anemia)

A Controlled comparative study to evaluate the effect of Navayas Loha in Pandu Roga(Iron Deficiency Anemia).

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074073
Enrollment
40
Registered
2024-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Sponsors

Akesh Nautiyal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having Hb percentage as follow for female 6 to 10 gm percentage for male 6 to 12 gm percentage

Exclusion criteria

Exclusion criteria: 1.Patients below 16 years and above 60 years. 2. Patient having Hb percentage less than 6 gm per dl 3. Patients having associated complicated systemic disorders like – AIDS, Cancer, CKD, Auto-immune disorders, any type of infection, cardiac disorders etc. 4.Pregnancy. 5.Anemia due to cause other than Iron deficiency.

Design outcomes

Primary

MeasureTime frame
Relief in Subjective Parameters 1.Panduta (pallor) 2.Akshikootshotha (periorbital swelling) 3.Hridayaspandana (palpitation) 4.Pindikodweshtana (cramps in calf region) 5.Aayasena shwasa (exertion dyspnoea) 6.Arochaka (food aversion) 7.Daurbalya (weakness) Timepoint: Assessment will be done at interval of 15 days i.e. on 15 day, 30 day, 45 day, 60 day

Secondary

MeasureTime frame
Relief in objective parameters 1.Hb percentage 2.Blood indices- MCV, MCH, MCHC 3.Serum Iron 4.Serum ferritin 5.TIBCTimepoint: Assessment will be done on 0 day and 60 day

Countries

India

Contacts

Public ContactAkesh Nautiyal

Uttarakhand ayurved university Gurukul campus Haridwar

dineshdr157@gmail.com9411731180

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026